These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29213570)

  • 1. Detecting cognitive impairment in patients with Parkinson's disease with a brief cognitive screening tool: the Addenbrooke's Cognitive Examination (ACE).
    Chade A; Roca M; Torralva T; Gleichgerrcht E; Fabbro N; Arévalo GG; Gershanik O; Manes F
    Dement Neuropsychol; 2008; 2(3):197-200. PubMed ID: 29213570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of the Addenbrooke's Cognitive Examination (Spanish version) in Peruvian patients with Alzheimer's disease and Frontotemporal Dementia].
    Custodio N; Lira D; Montesinos R; Gleichgerrcht E; Manes F
    Vertex; 2012; 23(103):165-72. PubMed ID: 23145370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addenbrooke's Cognitive Examination-Revised is accurate for detecting dementia in Parkinson's disease patients with low educational level.
    Rocha MSG; Bassetti EM; Oliveira MO; Kuark RGB; Estevam NM; Brucki SMD
    Dement Neuropsychol; 2014; 8(1):20-25. PubMed ID: 29213875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].
    Sarasola D; de Luján-Calcagno M; Sabe L; Crivelli L; Torralva T; Roca M; García-Caballero A; Manes F
    Rev Neurol; 2005 Dec 16-31; 41(12):717-21. PubMed ID: 16355355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argentinian/Chilean validation of the Spanish-language version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Bruno D; Slachevsky A; Fiorentino N; Rueda DS; Bruno G; Tagle AR; Olavarria L; Flores P; Lillo P; Roca M; Torralva T
    Neurologia (Engl Ed); 2020 Mar; 35(2):82-88. PubMed ID: 28865943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease.
    Sousa NMF; Brucki SMD
    Arq Neuropsiquiatr; 2023 Feb; 81(2):155-163. PubMed ID: 36863401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Malay Version of Addenbrooke's Cognitive Examination III in Detecting Mild Cognitive Impairment and Dementia.
    Kan KC; Subramaniam P; Shahrizaila N; Kamaruzzaman SB; Razali R; Ghazali SE
    Dement Geriatr Cogn Dis Extra; 2019; 9(1):66-76. PubMed ID: 31043965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Spanish version of the Addenbrooke's Cognitive Examination - Revised (ACE-R) in subcortical ischemic vascular dementia.
    Raimondi C; Gleichgerrcht E; Richly P; Torralva T; Roca M; Camino J; Manes F
    J Neurol Sci; 2012 Nov; 322(1-2):228-31. PubMed ID: 22959102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Addenbrooke's cognitive examination for detecting early dementia in a Japanese population.
    Yoshida H; Terada S; Honda H; Ata T; Takeda N; Kishimoto Y; Oshima E; Ishihara T; Kuroda S
    Psychiatry Res; 2011 Jan; 185(1-2):211-4. PubMed ID: 20537725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addenbrooke's Cognitive Examination validation in Parkinson's disease.
    Reyes MA; Perez-Lloret S; Roldan Gerschcovich E; Martin ME; Leiguarda R; Merello M
    Eur J Neurol; 2009 Jan; 16(1):142-7. PubMed ID: 19049504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Spanish Version of the Addenbrooke's Cognitive Examination-Revised (ACE-R).
    Torralva T; Roca M; Gleichgerrcht E; Bonifacio A; Raimondi C; Manes F
    Neurologia; 2011; 26(6):351-6. PubMed ID: 21232827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Portuguese version of Addenbrooke's Cognitive Examination-Revised (ACE-R) in the diagnosis of subcortical vascular dementia and Alzheimer's disease.
    Gonçalves C; Pinho MS; Cruz V; Pais J; Gens H; Oliveira F; Santana I; Rente J; Santos JM
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2015; 22(4):473-85. PubMed ID: 25430606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Mini-Addenbrooke's Cognitive Examination in Mild Cognitive Impairment in Arabic Speakers.
    Qassem T; Khater MS; Emara T; Rasheedy D; Tawfik HM; Mohammedin AS; Tolba MF; Aly El-Gabry D; Abdel Aziz K; Saber HG
    Dement Geriatr Cogn Disord; 2021; 50(2):178-182. PubMed ID: 34293741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.
    Kaszás B; Kovács N; Balás I; Kállai J; Aschermann Z; Kerekes Z; Komoly S; Nagy F; Janszky J; Lucza T; Karádi K
    Parkinsonism Relat Disord; 2012 Jun; 18(5):553-6. PubMed ID: 22405839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the Addenbrooke's Cognitive Examination III online calculator to differentiate the primary progressive aphasia variants.
    Foxe D; Hu A; Cheung SC; Ahmed RM; Cordato NJ; Devenney E; Hwang YT; Halliday GM; Mueller N; Leyton CE; Hodges JR; Burrell JR; Irish M; Piguet O
    Brain Commun; 2022; 4(4):fcac161. PubMed ID: 35912134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Sensitivity and Specificity of Addenbrooke's Cognitive Examination-I, III and Mini-Addenbrooke's Cognitive Examination in Parkinson's Disease.
    Lucza T; Ascherman Z; Kovács M; Makkos A; Harmat M; Juhász A; Janszky J; Komoly S; Kovács N; Dorn K; Karádi K
    Behav Neurol; 2018; 2018():5932028. PubMed ID: 30369997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation Study of the Chinese Version of Addenbrooke's Cognitive Examination III for Diagnosing Mild Cognitive Impairment and Mild Dementia.
    Li X; Yang L; Yin J; Yu N; Ye F
    J Clin Neurol; 2019 Jul; 15(3):313-320. PubMed ID: 31286702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brazilian Version of Addenbrooke's Cognitive Examination-Revised in the Differential Diagnosis of Alzheimer'S Disease and Behavioral Variant Frontotemporal Dementia.
    Amaral-Carvalho V; Lima-Silva TB; Mariano LI; de Souza LC; Guimarães HC; Bahia VS; Nitrini R; Barbosa MT; Yassuda MS; Caramelli P
    Arch Clin Neuropsychol; 2022 Feb; 37(2):437-448. PubMed ID: 34530438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.